Aduro Biotech Inc Conference Call in Conjunction with the 2017 ASCO Annual Meeting
Llamada en conferencia Aduro Biotech Inc
Aduro Biotech Inc Conference call or earnings call will be held on 03-jun-2017 via an 800 number (toll-free). During the earnings conference call's session Aduro Biotech Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Aduro Biotech Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
References herein to "we," "us," "Company", and "Aduro" refer to Aduro Biotech, Inc. and its consolidated subsidiaries unless the context specifically states otherwise. We are a clinical-stage immunotherapy company focused on the discovery, development and commercialization of therapies that transform the treatment of challenging diseases. Our first-in-class technology platforms, which are designed to harness the body's natural immune system, are being investigated in cancer indications and have the potential to expand into autoimmune and infectious diseases. Our Live, Attenuated, Double-Deleted, or LADD, Listeria monocytogenes technology platform is engineered to express tumor-associated antigens to induce specific and targeted immune responses. Based on compelling clinical data in advanced cancers, this platform is being developed as a treatment for multiple indications, including pancreatic, ovarian, lung and prostate cancers, mesothelioma and glioblastoma.Leer más Llamada en conferencia